Prevention and treatment of infectious conditions with active vitamin d compounds or mimics thereof
WO2008115499A1
Mannich base n-oxide drugs
WO2008103320A1
Methods of treating ophthalmic disorders with anthraquinones
WO2008118150A2
Nitric oxide synthase as a marker for treatment with bioreducible prodrugs
TW200833345A
Use of vitamin D compounds and mimics thereof to enhance delivery of therapeutics and oxygen to tumors and other tissues
US2008069814A1
Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof
WO2007098089A2
Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs
CA2642717A1
Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
WO2007098090A2
Treatment of hyperproliferative diseases with n-oxides of estrogen receptor modulators
US2009163453A1
Prevention and Treatment of Gastrointestinal and Bladder Disorders Associated with Chemotherapy or Radiation Therapy Using Active Vitamin D Compounds
US2007117784A1
Treatment of hyperproliferative diseases with anthraquinones
CA2606517A1
Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin d compounds or mimics thereof
ZA200709027B
Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof
AU2006220886A1
Treatment of hyperproliferative diseases with anthraquinones
ZA200706455B
Prevention of thrombotic disorders with active vitamin D compounds or mimics thereof
MX2007008227A
Prevention of thrombotic disorders with active vitamin d compounds or mimics thereof.
WO2006031719A2
1,4-bis-n-oxide-5,8-dihydroxyanthracenedione compounds and the use thereof
EP1750728A1
Prevention of arterial restenosis with active vitamin d compounds
EA010437B1
Pharmaceutical compositions c0mprising active vitamin d compounds
US2005020546A1
Pharmaceutical compositions comprising active vitamin D compounds
